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Abstract The participation of peroxisomal and microsomal 
fractions from rat liver in dolichol and cholesterol synthesis was 
investigated using marker enzymes. Recovery was 8% for per- 
oxisomes and 33% for microsomes, with virtually no cross-con- 
tamination between these fractions. Using these data, it was cal- 
culated that the peroxisomal branch-point enzyme activities for 
dolichol and cholesterol biosynthesis, i.e. cis-prenyltransferase 
and squalene synthase, were 25% and 12%, respectively, of the 
total homogenate activity. Treatment with mevinolin increased 
the peroxisomal contribution in the case of both enzymes, to levels 
almost equal to that of their microsomal counterparts. These 
results indicate that peroxisomes play a role in the biosynthesis 
of isoprenoid lipids and that the extent of this participation is 
increased extensively when peroxisomes are induced by various 
treatments. 
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1. Introduction 
Interest in this organelle has increased uring recent years, 
because of its extensive involvement in lipid metabolism. 
fl-Oxidation of long-chain and very-long-chain fatty acids, plas- 
malogen synthesis and involvment in bile acid production are 
among the peroxisomal functions which have been studied in 
great detail [8]. Peroxisomes exhibit an unusual capacity for 
adaptation: upon treatment of rodents with hypolipidemic 
drugs, other chemicals and in certain dietary conditions, the 
number of hepatic peroxisomes i  increased several-fold, with 
parallel and extensive induction of specific enzyme activities [9]. 
On the other hand, there are an increasing number of reports 
on diseases where some or most peroxisomal enzymes are ab- 
sent with serious consequences for cellular life [10,11]. 
In order to increase understanding of the importance of 
peroxisomal participation i isoprenoid metabolism, it is im- 
portant o quantitate the percentage of total hepatic dolichol 
and cholesterol synthesis which occurs in this organelle. This 
question is of considerable interest, since even a relatively low 
peroxisomal ctivity is often increased several-fold by physio- 
logical or pharmacological stimulation or under various pa- 
thological conditions. 
The initial reactions of the mevalonate pathway yield far- 
nesyl pyrophosphate (FPP), which is utilized for the synthesis 
of dolichol and cholesterol. FPP is also the substrate for trans- 
prenyltransferase, which forms the side-chain ofubiquinone [1]. 
FPP and its condensation product, geranylgeranyl pyro- 
phosphate (GGPP), also serve as substrates for protein isopren- 
ylation. 
Originally, the initial portion of the pathway was thought o 
be localized to the cytoplasm and the terminal reactions in 
dolichol and cholesterol synthesis were considered to occur in 
the microsomes. However, investigations in recent years have 
demonstrated the presence of various biosynthetic steps leading 
to mevalonate pathway lipids in several subcellar locations. In 
the presence of [3H]mevalonate and cytosol, not only micro- 
somes, but also peroxisomes, from rat liver can synthesize dol- 
ichol [2]. The properties of the peroxisomal cis-prenyltrans- 
ferase, the first commited enzyme of dolichol synthesis, were 
investigated and found to differ from those of the correspond- 
ing microsomal ctivity [3]. 
Peroxisomes are also able to synthesize cholesterol in the 
presence of [3H]mevalonate and cytosol [4,5]. Peroxisomal 
squalene synthase xhibits regulation by mevinolin and by var- 
ious inducers distinct from that of the microsomal enzyme [3,6]. 
Several other enzymes involved in cholesterol synthesis could 
also be detected in peroxisomes [7]. 
*Corresponding author. Fax: (46) (8) 153 679. 
2. Materials and methods 
Male Sprague-Dawley rats (180 g) were used without starvation. 
Mevinolin treated rats were fed chow mixed with mevinolin (500 mg/kg 
food) for 21 days. The livers were homogenized in a medium containing 
sucrose, EDTA and ethanol, and used for subfractionation as described 
earlier [7]. Peroxisomes were isolated from the light mitochondrial 
fraction by centrifugation  a preformed linear Nycodenz gradient. 
After centrifugation in a vertical rotor, the peroxisomal fraction, band- 
ing at a density of about 1.23 g/ml, was collected. The microsomal 
fraction was prepared by centrifugation f the 10,000 xg supernatant, 
at 105,000 xg for 120 rain. 
NADPH-cytochrome c reductase (NADPH-cyt. c red.), urate oxi- 
dase and catalase activities were measured as described earlier [12-14]. 
cis-Prenyltransferase activity in the subfractions was assayed by using 
[3H]isopentenyl p rophosphate and unlabeled FPP as substrates [15]. 
In the case of microsomes, the incubation medium contained 100 mM 
KF and 1.0% Triton X-100 and, for peroxisomes, 5 mM KF and no 
detergent. After incubation, the lipids were extracted with butanol and 
dephosphorylated enzymatically [16]. The polyprenols were quanti- 
rated by reversed-phase HPLC, with direct elution through aradioac- 
tivity flow-detector. 
For determination f squalene synthase activity, the incubation me- 
dium contained [3H]FPP as the only substrate [3]. The products were 
extracted with chloroform/methanol (2:1), and analyzed using reversed- 
phase HPLC. Protein was measured according to Lowry, with bovine 
serum albumin as the standard [17]. 
3. Results and discussion 
Contamination f isolated fractions by various membranes 
occurs when liver homogenate is fractionated. The presence of 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(94)01431-0 
J. Griinler et aL/FEBS Letters, 358 (1995) 230 232 231 
Table 1 
Specific activity of marker enzymes in total liver homogenate, micro- 
somes and peroxisomes 
Enzymes  Homogenate Microsomes Peroxisomes 
NADP-cyt. c red? 23 _+ 2.9 110 _+ 1.0 2.8 + 0.4 
Urate oxidase b 9.0 _+ 1.0 3.5 _+ 0.4 290 + 33 
Catalase ~ 410 _+ 50 62 _+ 7.0 4500 _+ 410 
The marker enzyme activities were determined in microsomes and per- 
oxisomes and were used to estimate cross-contamination. For micro- 
somes, the membrane enzyme NADPH-cytochrome c reductase was 
employed. In the case of peroxisomes, two enzymes were selected - 
urate oxidase, which is firmly associated with the vesicles, and catalase, 
which is easily released. The values are the mean + S.D. of six experi- 
ments. ~nmol cyt. c reduced/min/mg protein; bnmol urate oxidized/min/ 
mg protein; c/.tmol H202 decomposed/min/mg protein. 
microsomal vesicles in the peroxisomal fraction was estimated 
by determining the activity of NADPH-cytochrorne c reduc- 
tase, an endoplasmic reticulum (ER) membrane enzyme (Table 
1). Using Nycodenz as the density medium and a vertical rotor 
for separation, microsomal contamination f peroxisomes was 
negligible. 
Peroxisomal contamination f microsomes was estimated by 
measuring urate oxidase and catalase, enzymes pecifically as- 
sociated with peroxisomes. The peroxisomal contamination in 
microsomes was only 1 2%. Thus, there is virtually no cross- 
contamination between these two preparations and the frac- 
tions isolated are therefore very suitable for enzyme distribu- 
tion studies, at least from the point of view of purity. 
In any fractionation studies, high purity has a price, which 
is low recovery. In order to estimate organelle recovery from 
the homogenate, the marker enzymes, were assayed both in the 
homogenate and the isolated fractions (Table 2). The results 
with respect o NADPH-cytochrome c reductase activity indi- 
cated that the yield of the ER fragments in the microsomes was 
33% of the total. 
The yield of peroxisomes was estimated by measuring two 
enzymes known to show different behaviour. Urate oxidase is 
present as a crystalloid structure and is consequently not re- 
leased, even from broken peroxisomes [18]. On the other hand, 
catalase iseasily released from peroxisomes a are certain other 
enzymes present in the peroxisomal lumen. The recoveries of 
peroxisomes was quite poor, in agreement with previous tudies 
[19]. The yield calculated on the basis of urate oxidase distribu- 
tion, was about 8%, while recovery calculated using catalase 
was about 3%. Available xperiments indicate that the enzymes 
involved both in dolichol and cholesterol synthesis are rela- 
tively firmly associated with the inner peroxisomal compart- 
ment and, for this reason, we calculated our data using the 
value for recovery obtained with urate oxidase. 
With our isolation procedure, the protein content of the 
fraction consisting of microsomal vesicles (washed to remove 
adsorbed cytosolic proteins) was about 15 mg/g liver (Table 3). 
Thus, the total microsomal content of liver homogenate calcu- 
lated on the basis of a 33% recovery was 45 mg protein/g liver. 
The Nycodenz gradient procedure provides very pure per- 
oxisomes but the amount was only 0.5 mg protein/g liver. This 
value requires ubstantial correction for the low recovery rate 
so that 6 mg peroxisomal protein was actually present per g 
liver under normal conditions. 
The specific activity of the branch-point enzyme of dolichol 
synthesis, cis-prenyltransferase, was found to be 2.5-fold higher 
in peroxisomes than in microsomes (Table 4). Considering the 
relative recoveries, one may conclude that 75% of the total 
activity in the homogenate is localized in microsomes, while 
25% of this activity originates from peroxisomes. 
Upon mevinolin treatment, he specific activity doubled in 
peroxisomes and remained unchanged in microsomes. Conse- 
quently, about 43% of the total activity in the homogenate after 
this treatment was present in peroxisomes. 
The specific activity of squalene synthase was about he same 
in microsomes and peroxisomes (Table 5). It is known that 
during homogenization a d fractionation, the microsomal en- 
zyme may be subject o proteolysis, resulting in the release of 
an enzymatically active fragment into the cytosol [20]. With the 
mild homogenization procedure mployed here such protein 
hydrolysis was limited and only about 2% of the total squalene 
synthase activity was recovered in the cytosol. Quantitative 
calculation of the distribution of this branch-point enzyme in 
cholesterol biosynthesis revealed that 86% of the total activity 
was present in microsomes and 12% in peroxisomes. 
Mevinolin treatment increased the specific activity of 
squalene synthase in microsomes by 60% while in peroxisomes 
the increase was 12-fold. For this reason, 46% of the total 
activity in the homogenate was found to be peroxisomal. The 
cytosolic ontribution was less than 1%. cis-Prenyltransferase 
and squalene synthase are considered to be the terminal regula- 
tory enzymes of dolichol and cholesterol biosynthesis [21]. If 
these enzymes are rate-limiting in these biosynthetic processes, 
one can conclude that about 25% of dolichol and 12% of 
cholesterol synthesis in rat liver in vitro takes place in per- 
oxisomes. This calculation is, however, only approximative 
since we do not know to what extent in vitro measurements 
represent in vivo activities. This question will require detailed 
investigation in the future. Even a few percent synthetic activity 
can make up a substantial proportion since upon peroxisomal 
proliferation this contribution is increased several-fold, fl-Oxi- 
dation of fatty acids occurs predominantly in mitochondria, 
and the corresponding peroxisomal process plays a minor role 
from a quantitative point of view. Upon induction, however, 
Table 2 
Distribution of marker enzymes in isolated microsomes and peroxisomes 
Enzyme Homogenate Microsomes Peroxisomes 
Total activity Total acitivity Recovery % Total activity Recovery % 
NADPH-cyt. c red? 4.7 1.6 33 0.0014 
Urate oxidase b 1800 52 - 140 7.9 
Catalase c 84000 920 2300 2.7 
The marker enzyme activities were measured inhomogenate, microsomes and peroxisomes. The specific activities were used to calculate the amount 
of microsomes and peroxisomes in the homogenate in order to obtain the yield. The values are the mean of six experiments.a,umol cyt c reduced/min/g 
liver; bnmol urate oxidized/min/g liver; '~umol H202 decomposed/min/g liver. 
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Table 3 
Total protein content of microsomes and peroxisomes in liver homoge- 
nate 
Homo- Micro- Peroxi- 
genate somes somes 
Control 
Protein content in isolated 
fractions" 203 +_ 17 14.9 + 1.6 0.5 + 0.06 
Calculated total protein 
content a 203 + 20 45 + 5.3 6.1 + 0.5 
Mevinolin 
Protein content in isolated 
fractions a 211 + 15 15.7 + 1.8 0.5 + 0.07 
Calculated total protein 
content" 211 + 23 46.2 + 6 6.0 + 0.8 
The protein content in the homogenate, alkaline-washed microsomes 
and peroxisomes was determined after fractionation. Using the values 
obtained in Table 2, the total microsomal and peroxisomal protein 
content in the homogenate was calculated. The values are the 
mean + S.D. of six experiments. "mg/g liver. 
peroxisomal fatty acid fl-oxidation can be increased 30-50 
times [9]. 
Analysis of the organisation of biosynthetic sequences re- 
quires isolation of the individual enzymes involved in order to 
compare them chemically and functionally. In the case of fatty 
acid fl-oxidation it has been established that the peroxisomal 
enzymes involved are different from the mitochondrial ones 
[22]. This may also be the case for the branch-point enzymes 
investigated here. The regulation of both cis-prenyltransferase 
and squalene synthase in microsomes and peroxisomes occurs 
independently. This became clear when these enzyme activities 
were assayed after various dietary treatments, administration 
of inducers of peroxisomes and microsomes, drugs and other 
chemicals [6]. Obviously, the localization of these biosynthetic 
pathways in the two organelles raises not only quantitative 
considerations, but the lipids synthesized at these two locations 
may fulfil different functions. One suggestion is that the lipids 
produced in the endoplasmic reticulum participate in lipopro- 
tein production and membrane biogenesis, whereas those syn- 
thesized in peroxisomes may serve as substrates for further 
metabolism and also be transported to the bile, where they are 
constitutive components. 
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Table 4 
Distribution of cis-prenyltransferase in microsomes and peroxisomes 
Fraction Specific activity Total activity % of total activity 
(pmol/mg (nmol/g liver/h) in homogenate 
prot./h) 
Control 
Microsomes 270 + 30 12 + 1.5 75 
Peroxisomes 680 + 76 4.1 + 0.58 25 
Mevinolin 
Microsomes 260 + 30 12 + 1.9 57 
Peroxisomes 1480 + 160 9 + 1.3 43 
cis-Prenyltransferase activity was determined in the various fractions 
and the values given in Table 2, used to estimate the percentage distri- 
bution of the activities in the homogenate. The values are the 
mean _+ S.D. of four experiments. 
Table 5 
Distribution of squalene synthase activity in microsomes and per- 
oxisomes 
Fraction Specific activity Total activity % of total activity 
(pmol/mg (nmol/g liver/h) in homogenate 
prot./h) 
Control 
Microsomes 430 + 48 19.3 + 2.2 86 
Peroxisomes 418 + 43 2.6 _+ 0.29 12 
Cytosol 8.0 + 1.1 0.5 + 0.2 2 
Mevinolin 
Microsomes 716 + 75 33 + 3.8 54 
Peroxisomes 4730 + 520 28 + 3.4 46 
Cytosol 16 + 2.1 0.4 + 0.2 - 
The squalene synthase activity was measured in microsomes, per- 
oxisomes and cytosol. The data in Table 2 were used to calculate the 
percentage distribution of the activities in the homogenate. The values 
are the mean + S.D. of four experiments. 
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